Researchers found that the compound, called cannabidiol, had the ability to 'switch off' the gene responsible for metastasis in an aggressive form of breast cancer. Importantly, this substance does not produce the psychoactive properties of the cannabis plant.
Last year they published a study that found a similar effect in mice. Now they say they are on the verge of publishing further animal study results that expand these results further.
Speaking to the San Francisco Chronicle, study co-leader Dr Sean McAllister, said: 'The preclinical trial data is very strong, and there's no toxicity. There's really a lot or research to move ahead with and to get people excited.'



Flanked by top health officials including Health Secretary Robert F. Kennedy Jr., President Trump unveiled a...
Respiratory therapist Marcy Freeman doesn't need a research study to confirm for her a return to...
Cases of cyclosporiasis, a parasitic infection known for causing explosive diarrhea, have now reached 47 states...





























